Ledger.Open graph →
SEC Form D · filed March 12, 2018

Amarantus Bioscience Holdings, Inc

Offering
$1.5M
Sold
$300K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Gerald Commissiong · San Francisco, CAExec · DirectorDonald Huffman · Fremont, CADirectorJohn Commissiong · San Francisco, CAExec · DirectorRobert Harris · BROOKLYN, NYDirectorSteven Spence · San Francisco, CADirectorGerald Commissiong · San Francisco, CAExec · DirectorDonald Huffman · San Francisco, CADirectorJohn Commissiong · San Francisco, CAExec · DirectorRobert Harris · San Francisco, CADirectorSteven Spence · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗